+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Treatment attributes important to the treatment decision for early-stage prostate cancer A comparison between men-at-risk and patients



Treatment attributes important to the treatment decision for early-stage prostate cancer A comparison between men-at-risk and patients



Clinical & Investigative Medicine 23(4 Supplement): S7




(PDF emailed within 1 workday: $29.90)

Accession: 035980072

Download citation: RISBibTeXText


Related references

Comparison of four treatment options for low-risk prostate cancer: Preference-based randomized study for the evaluation of four treatment modalities in prostate cancer with low or "early intermediate" risk (PREFERE) - trial AP 65/11 of the AUO. Der Urologe. Ausg. a 54(5): 723-725, 2016

Cost-Effectiveness of a Biopsy-Based 8-Protein Prostate Cancer Prognostic Assay to Optimize Treatment Decision Making in Gleason 3 + 3 and 3 + 4 Early Stage Prostate Cancer. Oncologist 20(12): 1355-1364, 2016

Decision analysis for treatment of early stage prostate cancer. Japanese Journal Of Cancer Research. 89(6): 681-689, E, 1998

Information for decision making by patients with early-stage prostate cancer: a comparison across 9 countries. Medical Decision Making 31(5): 754-766, 2012

Impact of a web-based treatment decision aid for early-stage prostate cancer on shared decision-making and health outcomes: study protocol for a randomized controlled trial. Trials 16: 231, 2016

Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison. International Journal of Radiation Oncology, Biology, Physics 69(2): 444-453, 2007

Prostatectomy versus radiotherapy for early-stage prostate cancer (PREPaRE) study: protocol for a mixed-methods study of treatment decision-making in men with localised prostate cancer. Bmj Open 7(11): E018403, 2018

Helical tomotherapy and intensity modulated proton therapy in the treatment of early stage prostate cancer: a treatment planning comparison. RadioTherapy and Oncology 98(1): 74-80, 2011

The role of 3-dimensional mapping biopsy in decision making for treatment of apparent early stage prostate cancer. Journal of Urology 186(1): 80-85, 2011

Managing uncertainty about treatment decision making in early stage prostate cancer: a randomized clinical trial. Patient Education and Counseling 77(3): 349-359, 2011

In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453). International Journal of Radiation Oncology, Biology, Physics 69(4): 1333-4; Author Reply 1334-5, 2007

Important Factors Affecting Adjuvant Treatment Decision in Stage IA Breast Cancer Patients in Turkey. Breast Care 9(2): 123-127, 2014

Decision support for patients with early stage breast cancer Effects of an interactive CDROM on treatment decision, satisfaction, quality of life. European Journal of Cancer 36(Supplement 5): S125, 2000

Decision support for patients with early-stage breast cancer: effects of an interactive breast cancer CDROM on treatment decision, satisfaction, and quality of life. Journal of Clinical Oncology 19(6): 1676-1687, 2001

Cost Effectiveness of the Oncotype DX Genomic Prostate Score for Guiding Treatment Decisions in Patients With Early Stage Prostate Cancer. Urology 2018, 2018